Bidocef
Bidocef Brand names, Bidocef Analogs
Bidocef Brand Names Mixture
- None
Bidocef Chemical_Formula
C16H17N3O5S
Bidocef RX_link
http://www.rxlist.com/cgi/generic/cefadrox.htm
Bidocef fda sheet
Bidocef msds (material safety sheet)
Bidocef Synthesis Reference
L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)
Bidocef Molecular Weight
363.389 g/mol
Bidocef Melting Point
197oC
Bidocef H2O Solubility
1110 mg/L
Bidocef State
Solid
Bidocef LogP
-0.355
Bidocef Dosage Forms
Capsule; Tablet; Oral liquid
Bidocef Indication
For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes
Bidocef Pharmacology
Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.
Bidocef Absorption
Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.
Bidocef side effects and Toxicity
Nausea, vomiting, diarrhoea, allergic rashes may occur
Bidocef Patient Information
Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.
Bidocef Organisms Affected
Enteric bacteria and other eubacteria
